Valuation: Dermapharm Holding SE

Market Cap 2.33B 2.66B 2.15B 2.01B 3.78B 251B 3.86B 25.87B 9.99B 124B 9.99B 9.77B 431B P/E 2026 *
17.7x
P/E 2027 * 16.1x
Enterprise Value 3.12B 3.56B 2.88B 2.69B 5.06B 337B 5.18B 34.67B 13.38B 166B 13.38B 13.09B 577B EV / Sales 2026 *
2.58x
EV / Sales 2027 * 2.36x
Free-Float
10.7%
Yield 2026 *
2.16%
Yield 2027 * 2.39%
1 day+1.60%
1 week+2.47%
Current month-2.15%
1 month+1.17%
3 months+8.66%
6 months+21.22%
Current year+21.22%
1 week 45.85
Extreme 45.85
48.1
1 month 45.85
Extreme 45.85
49.2
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 2017-07-31
Director of Finance/CFO - 2022-10-31
Investor Relations Contact - 2018-11-30
Director TitleAgeSince
Chairman 70 2017-07-31
Director/Board Member 65 2017-07-31
Director/Board Member 77 2017-12-31
Date Insider Type Main position Quantity % Market Cap.
05-13Buy

Chairman

380,000 0.7670%
01-06Buy 150 0.0003%
01-06Buy 150 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.60%+2.47%+37.46%+5.30% 2.66B
+1.81%+11.60%+58.61%+164.79% 1,097B
+1.51%+11.77%+69.61%+57.53% 622B
+0.38%+10.56%+39.49%+90.88% 449B
-0.96%+6.34%+29.51%+24.01% 334B
+0.83%+6.42%+42.91%+28.25% 294B
+0.98%+3.29%+32.56%+41.64% 286B
+1.33%+3.69%-27.41%-41.95% 213B
+0.62%+4.59%+30.10%+63.03% 195B
-1.21%+1.17%+14.15%+66.20% 157B
Average +0.19%+6.21%+32.70%+49.97% 364.94B
Weighted average by Cap. +0.04%+8.71%+43.69%+82.02%

Financials

2026 *2027 *
Net sales 1.21B 1.38B 1.12B 1.04B 1.96B 130B 2.01B 13.43B 5.18B 64.38B 5.18B 5.07B 224B 1.25B 1.43B 1.16B 1.08B 2.04B 135B 2.08B 13.94B 5.38B 66.82B 5.38B 5.26B 232B
Net income 139M 159M 128M 120M 226M 15.01B 231M 1.54B 596M 7.4B 596M 583M 25.71B 155M 177M 143M 134M 252M 16.75B 258M 1.72B 665M 8.27B 665M 651M 28.7B
Net Debt 792M 905M 731M 683M 1.29B 85.53B 1.31B 8.8B 3.4B 42.19B 3.4B 3.32B 146B 636M 726M 587M 548M 1.03B 68.62B 1.05B 7.06B 2.73B 33.85B 2.73B 2.67B 118B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,503
Date Price Change Volume
26-06-30 47.70 +1.49% 2,445
26-06-29 €47.00 -1.26% 20,477
26-06-26 €47.60 +2.26% 11,290
26-06-25 €46.55 -0.85% 12,701
26-06-24 €46.95 +0.86% 11,194
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
47.00EUR
Average target price
50.38EUR
Spread / Average Target
+7.18%

Quarterly revenue - Rate of surprise